Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Fundación para la Innovación en Biomedicina

Spain C/ Alcalde Sainz de Baranda 39, 5º B, 28009 Madrid, Spain

About the sponsor

Research activity is centered on heart failure with preserved ejection fraction, with attention to the clinical features and cardiovascular burden of this condition.

  • Heart failure with preserved ejection fraction
  • Cardiac function
  • Cardiovascular disease

The sponsor’s funded work in this area reflects a focused interest in conditions where symptoms of heart failure occur despite maintained left ventricular ejection fraction.

About Specializations

Fundación para la Innovación en Biomedicina runs clinical trials in conditions such as Heart failure with preserved ejection fraction, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Heart failure with preserved ejection fraction

Not yet recruiting

Study on the Effects of Dapagliflozin for Patients with Heart Failure with Preserved Ejection Fraction

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.